Elevian Launches to Develop Regenerative Medicines for Age-Related Diseases

Sep 11, 2018

Elevian Launches to Develop Regenerative Medicines for Age-Related Diseases

Posted by Michael Greve in categories: biotech/medical, life extension, Peter Diamandis

Happy to announce our support for Elevian together with BOLD Capital and Peter Diamandis.

Commercializing scientific breakthroughs from Elevian’s scientific co-founders.

Comments are closed.

GETAS THREAT LEVEL: GUARDED
TOP DONOR: BRIAN CARTMELL
#2 DONOR: DONALD MACLEAN
#3 DONOR: JEFF BONE/TOPSIGHT FUND
#4 DONOR: PEG KAY

LF FUND: $591,125.40
BITCOIN ENDOWMENT: $6,448,689.82
A-PRIZE: $30,008.00
NANOSHIELD: $4,018.00
X-RISKS NETWORK: $3,104.00
AISHIELD: $4,109.00

LIFEBOAT NEWS: 2,811 SUBSCRIBERS
GETAS ALERTS: 414 SUBSCRIBERS
BLOG: 36,304 POSTS
BOARDS: 2,841 MEMBERS
REPORTS: 55
PROGRAMS: 25
FORUMS: 13
QUOTES: 136

FACEBOOK: 8,341 MEMBERS
LINKEDIN: 1,185 MEMBERS
TWITTER FEED: 34,228 MEMBERS
FIGHT AIDS: 4 MEMBERS
[email protected]: 15 MEMBERS
[email protected]: 39 MEMBERS
A-PRIZE: 55 MEMBERS
NANOSHIELD: 69 MEMBERS
AISHIELD: 25 MEMBERS

DONORS: 2,840
LF-500: 13 MEMBERS
PATRON: 1 MEMBER
FIRST CLASS: 1 MEMBER
EXECUTIVE: 12 MEMBERS
ECONOMY: 23 MEMBERS
A-500: 1 MEMBER

© 2002–2019 Lifeboat Foundation